These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16329078)

  • 21. Functional analysis of a duplication (p.E63_D69dup) in the switch II region of HRAS: new aspects of the molecular pathogenesis underlying Costello syndrome.
    Lorenz S; Lissewski C; Simsek-Kiper PO; Alanay Y; Boduroglu K; Zenker M; Rosenberger G
    Hum Mol Genet; 2013 Apr; 22(8):1643-53. PubMed ID: 23335589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutation.
    Denayer E; Parret A; Chmara M; Schubbert S; Vogels A; Devriendt K; Frijns JP; Rybin V; de Ravel TJ; Shannon K; Cools J; Scheffzek K; Legius E
    Hum Mutat; 2008 Feb; 29(2):232-9. PubMed ID: 17979197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive genetic analysis of overlapping syndromes of RAS/RAF/MEK/ERK pathway.
    Tumurkhuu M; Saitoh M; Sato A; Takahashi K; Mimaki M; Takita J; Takeshita K; Hama T; Oka A; Mizuguchi M
    Pediatr Int; 2010 Aug; 52(4):557-62. PubMed ID: 20030748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial storage of chondroitin sulfate-containing moieties in Costello syndrome patients with severe hypertrophic cardiomyopathy.
    Hinek A; Teitell MA; Schoyer L; Allen W; Gripp KW; Hamilton R; Weksberg R; Klüppel M; Lin AE
    Am J Med Genet A; 2005 Feb; 133A(1):1-12. PubMed ID: 15637729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mutations in H-Ras proto-oncogen in Costello syndrome].
    Dereure O
    Ann Dermatol Venereol; 2006; 133(8-9 Pt 1):731. PubMed ID: 17053754
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the pathogenesis of Costello syndrome.
    Mancini GM; van Diggelen OP; Kleijer WJ; Di Rocco M; Farina V; Yuksel-Apak M; Kayserili H; Halley DJ
    J Med Genet; 2003 Apr; 40(4):e37. PubMed ID: 12676910
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras/MAPK pathway syndrome.
    Lin AE; Alexander ME; Colan SD; Kerr B; Rauen KA; Noonan J; Baffa J; Hopkins E; Sol-Church K; Limongelli G; Digilio MC; Marino B; Innes AM; Aoki Y; Silberbach M; Delrue MA; White SM; Hamilton RM; O'Connor W; Grossfeld PD; Smoot LB; Padera RF; Gripp KW
    Am J Med Genet A; 2011 Mar; 155A(3):486-507. PubMed ID: 21344638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal dystrophy in two boys with Costello syndrome due to the HRAS p.Gly13Cys mutation.
    Pierpont ME; Richards M; Engel WK; Mendelsohn NJ; Summers CG
    Am J Med Genet A; 2017 May; 173(5):1342-1347. PubMed ID: 28337834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.
    Schulz AL; Albrecht B; Arici C; van der Burgt I; Buske A; Gillessen-Kaesbach G; Heller R; Horn D; Hübner CA; Korenke GC; König R; Kress W; Krüger G; Meinecke P; Mücke J; Plecko B; Rossier E; Schinzel A; Schulze A; Seemanova E; Seidel H; Spranger S; Tuysuz B; Uhrig S; Wieczorek D; Kutsche K; Zenker M
    Clin Genet; 2008 Jan; 73(1):62-70. PubMed ID: 18042262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel pathogenic variant in the HRAS gene with lethal outcome and a broad phenotypic spectrum among Polish patients with Costello syndrome.
    Pelc M; Ciara E; Jezela-Stanek A; Kugaudo M; Cieślikowska A; Jurkiewicz D; Janeczko M; Chrzanowska K; Krajewska-Walasek M; Skórka A
    Clin Dysmorphol; 2017 Apr; 26(2):83-90. PubMed ID: 28027064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel patient with an attenuated Costello syndrome phenotype due to an HRAS mutation affecting codon 146-Literature review and update.
    Chiu AT; Leung GK; Chu YW; Gripp KW; Chung BH
    Am J Med Genet A; 2017 Apr; 173(4):1109-1114. PubMed ID: 28328122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome.
    Zampino G; Pantaleoni F; Carta C; Cobellis G; Vasta I; Neri C; Pogna EA; De Feo E; Delogu A; Sarkozy A; Atzeri F; Selicorni A; Rauen KA; Cytrynbaum CS; Weksberg R; Dallapiccola B; Ballabio A; Gelb BD; Neri G; Tartaglia M
    Hum Mutat; 2007 Mar; 28(3):265-72. PubMed ID: 17054105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular confirmation of HRAS p.G12S in siblings with Costello syndrome.
    Gripp KW; Stabley DL; Geller PL; Hopkins E; Stevenson DA; Carey JC; Sol-Church K
    Am J Med Genet A; 2011 Sep; 155A(9):2263-8. PubMed ID: 21834037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costello syndrome: report and review.
    van Eeghen AM; van Gelderen I; Hennekam RC
    Am J Med Genet; 1999 Jan; 82(2):187-93. PubMed ID: 9934987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic and Genetic Characteristics of Five Korean Patients with Costello Syndrome.
    Choi N; Ko JM; Shin SH; Kim EK; Kim HS; Song MK; Choi CW
    Cytogenet Genome Res; 2019; 158(4):184-191. PubMed ID: 31394527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two cases with severe lethal course of Costello syndrome associated with HRAS p.G12C and p.G12D.
    Lorenz S; Petersen C; Kordaß U; Seidel H; Zenker M; Kutsche K
    Eur J Med Genet; 2012 Nov; 55(11):615-9. PubMed ID: 22926243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome.
    Rosenberger G; Meien S; Kutsche K
    Hum Mutat; 2009 Mar; 30(3):352-62. PubMed ID: 19035362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further evidence of genetic heterogeneity in Costello syndrome: involvement of the KRAS gene.
    Bertola DR; Pereira AC; Brasil AS; Albano LMJ; Kim CA; Krieger JE
    J Hum Genet; 2007; 52(6):521-526. PubMed ID: 17468812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe neonatal manifestations of Costello syndrome.
    Lo IF; Brewer C; Shannon N; Shorto J; Tang B; Black G; Soo MT; Ng DK; Lam ST; Kerr B
    J Med Genet; 2008 Mar; 45(3):167-71. PubMed ID: 18039947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early-lethal Costello syndrome due to rare HRAS Tandem Base substitution (c.35_36GC>AA; p.G12E)-associated pulmonary vascular disease.
    Weaver KN; Wang D; Cnota J; Gardner N; Stabley D; Sol-Church K; Gripp KW; Witte DP; Bove KE; Hopkin RJ
    Pediatr Dev Pathol; 2014; 17(6):421-30. PubMed ID: 25133308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.